Trial NCT03563742

View at ClinicalTrials.gov 
Org. Study IDs: CR108402
Secondary IDs: TMC278HTX3001

Last trial update was posted on 2022-06-29

MeSH Interventions

Lamivudine Rilpivirine Tenofovir

MeSH Conditions

Acquired Immunodeficiency Syndrome Communicable Diseases HIV Infections Immunologic Deficiency Syndromes Infections

Other Conditions

Human Immunodeficiency Virus Infections

Stopping Reasons

High SF rate (less treatment-naïve subjects & subjects with viral load <100000). Reevaluation in scientific position in India after internal discussion.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID